Increase in tumour-specific CD8+ T cells suggests that inhibition of IFNγ signalling in tumours might alter the cytokine environment, inducing global changes in signalling pathways of other immune subsets which we explored using genomic methods. The gene discussed is IFNG; the disease is neoplasm.